Literature DB >> 19159619

Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling.

Auemduan Prawan1, Constance Lay Lay Saw, Tin Oo Khor, Young-Sam Keum, Siwang Yu, Longqin Hu, Ah-Ng Kong.   

Abstract

Many cancer chemopreventive agents have been associated with lower cancer risk by suppressing nuclear factor-kappaB (NF-kappaB) signaling pathways, which subsequently leads to attenuated pro-inflammatory mediators and activities. Of the natural compounds, the isothiocyanates (ITCs) found in cruciferous vegetables have received particular attention because of their potential anti-cancer effects. However, limited studies regarding the influence of ITCs structure on NF-kappaB transactivation and anti-inflammatory action are reported. In the present study, the anti-inflammatory potential of ten structurally divergent synthetic ITCs were evaluated in HT-29-N9 human colon cancer cells and RAW 264.7 murine macrophages. The effect of ITCs on the basal transcriptional activation of NF-kappaB and the inflammatory response to bacterial lipopolysaccharide (LPS) were assessed. The synthetic ITC analogs suppressed NF-kappaB-mediated pro-inflammatory gene transcription. Among the ITC analogs, tetrahydrofurfuryl isothiocyanate, methyl-3-isothiocyanatopropionate, 3-morpholinopropyl isothiocyanate and 3,4-methyelendioxybenzyl isothiocyanate showed stronger NF-kappaB inhibition as compared to the parent compound, phenylethyl isothiocyanate (PEITC). Molecular analysis revealed that several of the pro-inflammatory mediators and cytokines (iNOS, COX-2, IL-1beta, IL-6 and TNF-alpha) were reduced by ITCs, and correlated with the downregulation of NF-kappaB signaling pathways. Immunoblotting showed that ITCs suppressed LPS-induced phosphorylation and degradation of IkappaB alpha and decreased nuclear translocation of p65. In parallel, ITCs suppressed the phosphorylation of IkappaB kinase alpha/beta (IKKalpha/beta). Taken together, our findings provide the possibility that synthetic ITC analogs might have promising cancer chemopreventive potential, based on their stronger anti-NF-kappaB and anti-inflammatory activities, than the natural ITCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19159619      PMCID: PMC2678965          DOI: 10.1016/j.cbi.2008.12.014

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  47 in total

Review 1.  Brassica vegetables and cancer prevention. Epidemiology and mechanisms.

Authors:  G van Poppel; D T Verhoeven; H Verhagen; R A Goldbohm
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.

Authors:  S Huang; C A Pettaway; H Uehara; C D Bucana; I J Fidler
Journal:  Oncogene       Date:  2001-07-12       Impact factor: 9.867

3.  Use of a murine cell line for identification of human nitric oxide synthase inhibitors.

Authors:  Saule Naureckiene; Wade Edris; Seena K Ajit; Alan H Katz; Kodangattil Sreekumar; Kathryn E Rogers; Jeffrey D Kennedy; Philip G Jones
Journal:  J Pharmacol Toxicol Methods       Date:  2006-08-17       Impact factor: 1.950

4.  Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis.

Authors:  Yang-Ming Yang; C Clifford Conaway; J W Chiao; Chung-Xiou Wang; Shantu Amin; John Whysner; Wei Dai; Joel Reinhardt; Fung-Lung Chung
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

Review 5.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

Authors:  Y J Surh; K S Chun; H H Cha; S S Han; Y S Keum; K K Park; S S Lee
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

Review 6.  Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis.

Authors:  M Jaiswal; N F LaRusso; G J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

Review 7.  Role of nitric oxide in carcinogenesis and tumour progression.

Authors:  P K Lala; C Chakraborty
Journal:  Lancet Oncol       Date:  2001-03       Impact factor: 41.316

Review 8.  Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence.

Authors:  Alan R Kristal; Johanna W Lampe
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

9.  Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase.

Authors:  Yi-Rong Chen; Jin Han; Rajashree Kori; A-N Tony Kong; Tse-Hua Tan
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

Review 10.  Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans.

Authors:  C Clifford Conaway; Yang-Ming Yang; Fung-Lung Chung
Journal:  Curr Drug Metab       Date:  2002-06       Impact factor: 3.731

View more
  24 in total

Review 1.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

2.  Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway.

Authors:  Zhigang Guo; Han Wang; Jun Wei; Liang Han; Zhaohui Li
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

Review 3.  Proteins as binding targets of isothiocyanates in cancer prevention.

Authors:  Lixin Mi; Anthony J Di Pasqua; Fung-Lung Chung
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

4.  Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.

Authors:  Hollie I Swanson; Vincent C O Njar; Zhen Yu; David J Castro; Frank J Gonzalez; David E Williams; Ying Huang; Ah-Ng T Kong; Joshua C Doloff; Jie Ma; David J Waxman; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2010-04       Impact factor: 3.922

Review 5.  Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.

Authors:  Gaurav Kumar; Hardeep Singh Tuli; Sonam Mittal; Jitendra Kumar Shandilya; Anil Tiwari; Sardul Singh Sandhu
Journal:  Tumour Biol       Date:  2015-04-03

6.  Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin.

Authors:  Hila Yehuda; Yoram Soroka; Marina Zlotkin-Frušić; Amos Gilhar; Yoram Milner; Snait Tamir
Journal:  Inflamm Res       Date:  2012-03-28       Impact factor: 4.575

7.  Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis.

Authors:  Tien-Yuan Wu; Tin Oo Khor; Constance Lay Lay Saw; Stephanie C Loh; Alvin I Chen; Soon Sung Lim; Jung Han Yoon Park; Li Cai; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2010-10-22       Impact factor: 4.009

8.  A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes.

Authors:  Anna Scotto d'Abusco; Laura Politi; Cesare Giordano; Roberto Scandurra
Journal:  Arthritis Res Ther       Date:  2010-01-29       Impact factor: 5.156

9.  Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells.

Authors:  Xiang Wu; Yu Zhu; Huiqin Yan; Boning Liu; Ying Li; Qinghua Zhou; Ke Xu
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

Review 10.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.